A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Appointment supports AstraZeneca’s $50 billion US investment and ambition to reach $80 billion in Total Revenue by 2030
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Patients can now get the starting 2.5 mg dose for $299 per month
The initiative aims to connect startups and tech companies with its business units,
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Subscribe To Our Newsletter & Stay Updated
